[1] Working CIOMS Group Ⅳ. benefit-risk balance for marketed drugs: evaluating safety signals [R]. Geneva: Council for International Organizations of Medical Sciences, 1998. [2] Christine R, Elaine M, Kenneth H, et al.Benefit-risk assessment, communication, and evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist[J]. Pharmacoepidemiology and Drug Safety, 2015, 24: 1233-1240. [3] The State Council of the People's Republic of China. Notice of the state council on issuing the national drug safety "twelfth five-year" plan [EB/OL]. (2012-01-12) [2021-01-05]. http://www.gov.cn/zwgk/2012-02/13/content_2065197.htm. [4] The State Council of the People's Republic of China. Notice of the state council on printing and distributing the "thirteenth five-year" national food safety plan and the "thirteenth five-year" national drug safety plan [EB/OL]. (2017-02-14) [2021-01-05]. http://www.gov.cn/zhengce/content/2017-02/21/content_5169755.htm. [5] National Medical Products Administration. The comprehensive department of national medical products administration for public consultation on the "Pharmacovigilance quality management standard" [EB/OL].(2021-05-13)[2021-05-13]. https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20210513151827179.html. [6] Gao G.Evaluation method of comprehensive analysis of drug benefit risk[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2012, 21(11): 569-573. [7] Zhang Y, Liu C, Wang SY, et al.Research on benefit risk evaluation system and main points of evaluation at home and abroad[J]. Central South Pharmacy(中南药学), 2018, 16(3): 427-432. [8] Lu YM, Zhang MH, Wu ZA.Overview of drug benefit-risk assessment research progress[J]. Chinese Journal of Pharm-acovigilance(中国药物警戒), 2013, 10(8): 473-477. [9] Li MC, Liu X, Liu BG.Drug benefit and risk assessment management[J]. Pharmaceutical Journal of Chinese People's Liberation Army(解放军药学学报), 2010, 26(2): 178-179. [10] Mt-Isa S, Hallgreen CE, WangN, et al. Balancing benefit and risk of medicines: a systematic review and classification of available method-ologies[J]. Pharmacoepidemiology and Drug Safety, 2014, 23: 667-678. [11] Hughes D, Waddingham E, Mt-Isa S, et al.Recommendations for benefit-risk assessment methodologies and visual representations[J]. Pharmacoepidemiology and Drug Safety, 2016, 25: 251-262. [12] Guo JJ, Pandey S, Doyle J, et al.A Review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group[J]. Value in Health, 2010, 13(5): 657-666. [13] Jiang H, Zhang XM, Zhang B, et al.Benefit and risk of tripterygium glycosides tablets in treatment of rheumatoid rheumatoid arthritis based on multi-criteria decision-making analysis[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2020, 45(4): 798-808. [14] Zhang XM, Jin YN, Zhang B, et al.Aconitum in treatment of rheumatoid arthritis: benefit-risk assessment[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2018, 43(2): 234-241. [15] Zhang XM, Lin ZJ, Zhang B, et al.Comparison of aconitum with tripterygium in treatment of axial spondyloarthritis: a benefit-risk assessment[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(2): 103-109. [16] Chen ZW, Sun J, Li YM, et al.Efficacy of Shenshi Qianghuo Dihuang decoction in rheumatoid arthritis: a randomized controlled trial[J]. Journal of Integrative Medicine(中西医结合学报), 2010, 8(1): 35-39. [17] Chen ZL, Zhang S.Curative effect observation of modified Guizhi Shaoyao Zhimu decoction and Yishen Chushi Pills in treating rheumatoid arthritis[J].Chinese Traditional Patent Medicine(中成药), 2017, 39(7): 1539-1541. [18] Dong MJ, Jiang CQ, Gao JZ.Clinical study on treatment of rheumatoid arthritis with acupuncture and Xibikang decoction[J]. Shandong Journal of Traditional Chinese Medicine(山东中医杂志), 2010, 29(7): 465-467. [19] Fan HM, Yuan BH.Curative effect observation of Guizhi Shaoyao decoction in the treatment of rheumatoid arthritis[J].Journal of Qiqihar Medical University(齐齐哈尔医学院学报), 2012, 33(19): 2636-2637. [20] Gu YM, Ding XR.Observation of TCM internal and external with etanercept on the treatment of rheumatoid arthritis[J]. Liaoning Journal of Traditional Chinese Medicine(辽宁中医杂志), 2010, 37(9): 1726-1728. [21] Guo F, Zheng XM, Xie SH.Efficacy observation on treating 72 cases of RA in the integrative medicine[J]. Clinical Journal of Chinese Medicine(中医临床研究), 2012, 4(6): 69-70. [22] Hu JW, Zhang PN.Effect of treatment of cold dampness blockage type rheumatoid rthritis with combination of TCM and Western Medicine[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药杂志), 2016, 9(8): 1-2, 13. [23] Jiang X.Effect and survival quality observation of the Bitongling Apoz-em used to treat rheumatoid arthritis of cold-dampness type[D]. Nan-jing: Nanjing University Of Chinese Medicine, 2007. [24] Jiang D, Wu J.Analysis and evaluation of the efficacy of Chinese medicine self-made prescriptions combined with Antirheumatic Drugs in the treatment of active rheumatoid arthritis[J]. Journal of Modern Medicine & Health(现代医药卫生), 2016, 32(22): 3507-3510. [25] Li FY.36 Cases of juvenile rheumatoid arthritis treated with integrated traditional Chinese and western medicine[J]. Chinese Journal of Applied Clinical Pediatrics(实用儿科临床杂志), 2004, 19(11): 1004-1005. [26] Li X.Clinical observation on therapy of rheumatoidarthritis with arthragia-blockade syndrome by means of warming and smoothing meridian[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2010, 12(11): 152-154. [27] Li GD.Experience in the treatment of rheumatoid arthritis with integr-ated traditional Chinese and western medicine[J]. Liaoning Journal of Traditional Chinese Medicine(辽宁中医杂志), 2011, 38(1): 118-119. [28] Li XL, Deng GZ, Li J.Clinical observation on 41 cases of rheumatoid arthritis treated with integrated traditional Chinese and western medicine[J]. Journal of Practical Traditional Chinese Medicine(中医药导报), 2014, 20(16): 62-65. [29] Li WH.Rheumatic arthralgia parallel randomized controlled study Aconitum treated[J]. Journal of Practical Traditional Chinese Internal Medicine(实用中医内科杂志), 2015, 29(8): 9-10. [30] Liang JM.Kindhearted yiyiren decoction in the treatment of rheumatoid Arthritis clinical research[D]. Wuhan: Hubei University Of Traditional Chinese Medicine, 2012. [31] Liu YN.Clinical observation of rheumatoid arthritis treated with Sanxiao yinzi Decoction combined with leflunomide[J]. Journal of Hunan University of Chinese Medicine(湖南中医药大学学报), 2011, 31(6): 17-18,20. [32] Lu WJ.Clinical study of Warming Yang, Dispelling Cold, Tonifying Qi and Dredging Collaterals method in the treatment of rheumatoid arthritis[J]. Acta Chinese Medicine(中医学报), 2014, 29(10): 1525-1527. [33] Luo SJ.The curative effect observation of modified aconiti decoction on reactiveness rheumatoid arthritis[J]. Acta Chinese Medicine(河南中医学院学报), 2009, 24(4): 71-72. [34] Ma WK, Zhong Q, Yao JM, et al.Effect of the Jinwu Jiangu decoction for rheumatoid arthritis with methotrexate resistance[J]. Journal of Traditional Chinese Medicine(中医杂志),2010, 51(11): 993-995. [35] Mai TX.Influence of integrated traditional Chinese and western medicine treatment and nursing on the clinical efficacy of active rheumatoid arthritis[J]. Journal of Frontiers of Medicine(医药前沿), 2013 (19) : 137-138. [36] Mao LZ, Huang LH, Wu DQ.Effect and nursing of erteng aconite decoction for rheumatoid arthitis in activity[J]. Heilongjiang Medical Journal(黑龙江医学), 2013, 37(3): 220-222. [37] Zhu JH.Observation on curative effect of Guizhi Shaoyao Zhimu decoction and Juanbi decoction in treating rheumatoid arthritis[J]. Shaanxi Journal of Traditional Chinese Medicine(陕西中医), 2014, 35(8): 984-986. [38] Piao WJ.Clinical observation on treating rheumatoid arthritis with comprehensive therapy of traditional Chinese medicine[J]. Guide of China Medicine(中国医药指南), 2014, 12(34): 280-281. [39] Shi L.Clinical study on treatment of rheumatoid arthritis with Tongbi No. 2[D].Wuhan: Hubei University Of Traditional Chinese Medicine, 2006. [40] Sun W, Sun Y.Clinical observation on efficacy of integrative medicine in 48 cases of rheumatoid arthritis patients[J]. China Modern Doctor(中国现代医生), 2011, 49(12): 58-59. [41] Tang W.Clinical observation on the treatment of 30 cases of rheumatoid arthritis[J]. Guiding Journal of Traditional Chinese Medicine and Pharmacy(中医药导报), 2011, 17(4): 67-68. [42] Tian Q.Treatment of 30 cases with cold and dampness Bi syndrome by modified Wutou decoction[J]. Clinical Journal of Chinese Medicine(中医临床研究) , 2014, 6(24): 55-56. [43] Wang GQ, Yan MH.30 Cases of rheumatoid arthritis treated by Fengshi decoction[J]. Medical Innovation of China(中国医学创新), 2010, 7(30): 65-66. [44] Wang HT.Clinical observation of treatment of rheumatoid arthritis with Sisheng Juanbi Decoction[J]. Clinical Journal of Chinese Medicine(中医临床研究), 2015, 7(9): 79-81. [45] Wang LS.Clinical study on Wenbi Decoction in treating rheumatoid arthritis of Cold-Dampness Blocking Type[D]. Zhengzhou: Henan University of Chinese Medicine, 2016. [46] Yu JW, Liu FD, Zhang WB.Clinical observation on 46 cases of rheumatoid arthritis treated with integrated traditional Chinese and western medicine[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy(中国民族民间医药), 2014, 23(11): 56-57. [47] Zhang XL.Clinical observation on treatment of rheumatoid arthritis with Dihuang mixture[J]. Chinese Journal of Medicinal Guide(中国医药导刊), 2010, 12(8): 1383-1384. [48] Zhang PK, Zhang GS, Yang KP.Clinical observation on the treatment of cold-dampness-blockage-type rheumatoid arthritis with Qubi Tang[J]. Combing Small-dose Methotrexate(风湿病与关节炎), 2016, 5(4): 25-27. [49] Zheng XM, Mao LZ, Mai TX, et al.Clinical study on Erteng Wutou decoction in the treatment of active rheumatoid arthritis[J]. Shandong Journal of Traditional Chinese Medicine(山东中医杂志), 2012, 31(9): 636-638. [50] Zhu YC, Huang LH.The curative effect and nursing of Chinese medicine Aconitum in treating rheumatoid arthritis[J]. Chinese General Practice Nursing(全科护理), 2009, 7(33): 3023-3024. |